Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $10.5400 (0.86%) ($9.9000 - $10.8500) on Tue. Jun. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.34% (three month average) | RSI | 46 | Latest Price | $10.5400(0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.17% in a week (0% probabilities). VIXM(-33%) VXX(-28%) UUP(-10%) UNG(-10%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.17% (StdDev 8.34%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
1 - 5 Day Possible Target | $-18.03(-271.06%) | Resistance Level | $11 | 5 Day Moving Average | $9.84(7.11%) | 10 Day Moving Average | $9.98(5.61%) | 20 Day Moving Average | $11(-4.18%) | To recent high | -29.4% | To recent low | 85.2% | Market Cap | $783m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |